Results 11 to 20 of about 423,577 (305)

Compulsory licensing for expensive medicines

KCE Reports, 2022
p.1-119; P1-64; P1-4 ill., Part 1 – Legal study 1 INTRODUCTION 9 -- 2 THE PHARMACEUTICAL SECTOR: TRENDS, PRACTICES AND CHARACTERISTICS OF THE LEGAL AND GOVERNANCE FRAMEWORK 12 -- 2.1 INTRODUCTION .12 -- 2.2 KEY STAKEHOLDERS & INNOVATION TRENDS IN THE PHARMACEUTICAL SECTOR 12 -- 2.3 CHARACTERISTICS RELEVANT LEGAL FRAMEWORK PHARMACEUTICAL SECTOR 14 -- 2 ...
Van Zimmeren, Esther, Minssen, Timo, Paemen, Liesbet, Van Dyck, Walter, Luyten, Jeroen, Janssens, Rosanne, Barbier, Liese, Simoens, Steven, Pouppez, Celine, Cleemput, Irina, Vinck, Irm   +10 more
semanticscholar   +8 more sources

Compulsory Licensing in Intellectual Property Rights (IPR): Current Application and Future Prospects in Indonesia

Fiat Justisia
The implementation of Compulsory Licensing in the procurement of anti-retroviral drugs to combat the HIV/AIDS epidemic, which poses a significant threat to Indonesia and global public health, exemplifies the essential necessity and utility of this ...
Sahlan Sahlan, Ilham Nurman, Abdul Karim Uddin, Andi Bustamin Daeng Kunu   +3 more
doaj   +2 more sources

Compulsory Licensing

Encyclopedia of Law and Economics, 2021
Compulsory licensing is a statutorily created nonexclusive license by the competent authority granted to a third party to make, use, or sell an invention, where remuneration is paid to the right holder and the right holder maintains his legal intellectual property rights.
B. Kianzad
openaire   +3 more sources

Compulsory Licensing of Pharmaceuticals in High-Income Countries: A Comparative Analysis. [PDF]

Milbank Q, 2022
Policy Points Pharmaceutical trade organizations and media outlets in the United States regularly point to compulsory licensing-or even its threat-as the mechanism that peer countries use to control the price of prescription drugs.
Qunaj L, Kaltenboeck A, Bach PB.
europepmc   +2 more sources

Budget impact analysis of two treatment approaches for hepatitis C in Malaysia through the use of voluntary and compulsory licensing options. [PDF]

Front Public Health, 2023
Introduction A scaled-up treatment cascade with direct-acting antiviral (DAA) therapy is necessary to achieve global WHO targets for hepatitis C virus (HCV) elimination in Malaysia.
Azzeri A, Dahlui M, Mohamed R, McDonald SA, Jaafar H, Shabaruddin FH.   +5 more
europepmc   +2 more sources

Trade-Related Aspects of Intellectual Property Rights Flexibilities and Public Health: Implementation of Compulsory Licensing Provisions into National Patent Legislation. [PDF]

Milbank Q, 2023
Policy Points Given the challenges associated with negotiating the COVID-19 Trade-Related Aspects of Intellectual Property Rights (TRIPS) Waiver, there are questions as to whether the World Trade Organization is able to effectively address pandemics and ...
McGIVERN L.
europepmc   +2 more sources

The case for compulsory licensing during COVID-19. [PDF]

J Glob Health, 2020
Wong H.
europepmc   +2 more sources

Compulsory Licensing in Other Countries [PDF]

Law and Contemporary Problems, 1948
Federico, P. J.
openaire   +4 more sources

Compulsory Licensing vs. the IP Waiver: What Is the Best Way to End the COVID-19 Pandemic?

Social Science Research Network, 2021
This policy brief examines the currently discussed proposals at the WTO that aim to resolve the problem of the production shortages of COVID-19 vaccines. This includes the two key submissions, i.e. the proposal by South Africa and India on the IP waiver,
Gurgula O.
europepmc   +2 more sources

The WHO pandemic agreement: why countries will not use compulsory licensing – and how to fix it [PDF]

BMJ Global Health
WooJung Jon
doaj   +2 more sources